abdm, BRR and Agent86...thanks for your posts.
I concur wholeheartedly with your opinions, and I too think that not only will our path to FDA approval be easier, but it will also be a LOT cheaper, thanks to our big brothers good work. I also think that based on what Management have said regarding trialling CVac on multiple different cancers that the savvy US investors will pick up on this and realise that PRR has every chance(IMO an extremely good chance) of being BIGGER than Dendreon!!!
And robhood...Southern Cross have a reputation to uphold, so they are hardly going to come out and say that PRR should be worth $1 or more...oh no hang on...that is exactly what they said!!!
Keep up the great work guys! Looking forward to the revised edition BRR.
the valuation exercise, page-38
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.010(2.78%) |
Mkt cap ! $537.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 36.0¢ | $563.7K | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 386559 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 261422 | 13 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |